Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-31 @ 2:09 PM
Study NCT ID:
NCT00870194
Status:
COMPLETED
Last Update Posted:
2015-04-09
First Post:
2009-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-25
First Submit QC Date:
None
Study First Post Date:
2009-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-11
Results First Submit QC Date:
None
Results First Post Date:
2011-06-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-20
Last Update Post Date:
2015-04-09
Last Update Post Date Type:
ESTIMATED